NewsResearch
CAPP2: What the Colorectal cancer Trial Found
CAPP2 tested aspirin in Lynch syndrome in colorectal cancer, measuring colorectal-cancer incidence. Plain-language summary of a positive result on its main measure — and what it doesn't mean.
Original commentary from the Cancer Explained editorial team.
Historical context: this page explains an event dated 2011. It was published as an explainer on July 12, 2026 and is not breaking news.
Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.
In brief
CAPP2 was randomized prevention trial in colorectal cancer that compared aspirin in Lynch syndrome and measured colorectal-cancer incidence. It reported a positive result on its main measure.
Trial at a glance
| Field | Detail |
|---|---|
| Trial | CAPP2 |
| Identifier | Not recorded here |
| Phase | See report |
| Design | randomized prevention trial |
| Cancer type | Colorectal cancer |
| Comparator | aspirin in Lynch syndrome |
| Primary endpoint | colorectal-cancer incidence |
| Reported result | A positive result on its main measure |
Who took part
The trial enrolled the population described in its report for colorectal cancer.
The main result
The trial's main finding concerned colorectal-cancer incidence: CAPP2 reported a positive result on its main measure. Full numbers, follow-up, and statistical detail are held for verification against the peer-reviewed report or trial registry.
What the result means
Results like this help shape research and, sometimes, care — but a trial's finding is one piece of evidence, tied to the specific people and design it used.
What to keep in perspective
- A positive trial does not automatically mean a treatment is approved or available; approval and access are separate steps.
- Improvement on one measure does not always translate into every outcome that matters to patients.
- Trial participants are selected by specific criteria, so results may not apply to everyone with this cancer.
If this is relevant to you, questions to ask
- Does this apply to my specific cancer type and situation?
- Is this treatment approved and available, or still investigational?
- What are the main side effects, and how would they be managed?
Sources
This article was written from the sources below, which were checked on the source-check date shown above.
How this article was prepared
Prepared by Cancer Explained's AI-assisted editorial system and checked against the sources listed below. This article has not been reviewed by a healthcare professional unless a named reviewer is specifically shown.
Cancer Explained is published by the National Cancer Information Foundation as a nonprofit-oriented public-interest education project. It is not a diagnostic service, does not recommend treatments, and is not for emergencies.
Found an error, a broken source link, outdated information, or wording that feels insensitive? Report it here — we log and act on material corrections.